AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Gmryl-MP2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Gms Biomax Medicare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Gmryl-MP2 Tablet ER

Metformin-pioglitazone extended-release tablets manage blood glucose levels in adults with type 2 diabetes. Used alongside diet and exercise, this dual-action medication enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and regimen; take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling up. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals require medical consultation. Kidney function will be assessed before treatment begins. Limit alcohol consumption to mitigate potential adverse effects.

Primary Ingredients of Gmryl-MP2 Tablet ER

There is no text provided to rephrase.

Uses of Gmryl-MP2 Tablet ER

Managing Type 2 diabetes

Major Benefits of Gmryl-MP2 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Gmryl-MP2 Tablet ER should be taken with a meal.

Common Side effects of Gmryl-MP2 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Gmryl-MP2 Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gmryl-MP2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Gmryl-MP2 Tablet ER works:

Gmryl-MP2 Extended-Release tablets contain a triple combination of glimepiride, metformin, and pioglitazone, each addressing blood glucose control through distinct pathways. This approach enhances blood sugar management when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gmryl-MP2 Tablet ER and alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gmryl-MP2 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Gmryl-MP2 tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gmryl-MP2 Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gmryl-MP2 Extended-Release tablets. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Gmryl-MP2 Tablet ER; dosage modification may be necessary. Consult your physician. Gmryl-MP2 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Gmryl-MP2 Tablet ER :

Should you forget a Gmryl-MP2 Tablet ER dose, take it immediately if convenient. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Gmryl-MP2 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Gmryl-MP2 Tablet ER

Combining Gmryl-MP2 Tablet ER and alcohol is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise your risk of lactic acidosis.
Consult your doctor before taking Gmryl-MP2 Tablet ER if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Metformin, a component of Gmryl-MP2 Tablet ER, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Gmryl-MP2 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep out of reach of children, pets, and others.
Gmryl-MP2 Tablet ER
74
MRP 90
17% off